The Online Investor
Seelos Therapeutics Inc (SEEL)

Seelos Therapeutics is a clinical-stage biopharmaceutical company focused on the development of products that address unmet needs in Central Nervous System disorders and other disorders. Co.'s primary programs are SLS-002 for the potential treatment of Acute Suicidal Ideation and Behavior in patients with Major Depressive Disorder and SLS-005 for the potential treatment of Amyotrophic Lateral Sclerosis and Spinocerebellar Ataxia. SLS-005 for the potential treatment of Sanfilippo Syndrome requires additional natural history data, which is being considered. Co. is also developing several preclinical programs, including SLS-004 and SLS-007, for the potential treatment of Parkinson's Disease.
Company Name: 
Seelos Therapeutics Inc
Website: 
www.seelostherapeutics.com
Sector: 
Drugs & Pharmaceuticals
Number of ETFs Holding SEEL: 
3
Total Market Value Held by ETFs: 
$173788
Total Market Capitalization: 
$7.00M
% of Market Cap. Held by ETFs: 
2.48%
Quotes delayed 20 minutes

Email EnvelopeFree SEEL Email Alerts:
Get SEC Filing Alerts
Get Dividend Alerts

Buy (3.33 out of 4)
46th percentile
(ranked lower than approx. 54% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Seelos Therapeutics Inc (SEEL) Page | The Online Investor Page | www.TheOnlineInvestor.com

Copyright © 1998 - 2024, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.